ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$CRL:NYSE · CHARLES RIV LABS INTL INC

Sector: healthtesting

Conviction from: S&PCitrini

52-week range: 146.19379.63

Charles River Laboratories provides preclinical and clinical drug-development services, research models, and manufacturing-support services to pharmaceutical and biotech companies.

4 tracked filer(s) hold this · 2 opened, 1 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 57 — mean of 4 scored holder(s) · buyers (new/add) avg 53. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Bridgewater55New buy70,553$20,813,8410.1%
Paul Tudor Jones / Tudor61New buy44,921$13,252,1440.0%
Ancora42Added +4%58$17,1110.0%
Bill Nygren / Oakmark (Harris Associates)71Trimmed -37%1,410,332$416,062,0430.5%

Beyond 13F — activists, insiders, politicians & research

Trump & executive branch trades all Trump/exec trades →

2 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-07-01Trump, Donald J PresidentSELL$15,001 - $50,000PTR
2026-05-14Trump, Donald J PresidentBUY$15,001 -$50,000PTR

Citrini Research coverage report library →

ReportDateStance
#135 — State of the Themes: The End of the Trade (As We Know It)2026-11-04LONG
#134 — Citrini Therapeutics: We Wanted to Use Claude to Create a New Drug2026-10-20LONG
#97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami2025-05-28WATCH
#92 — Market Memo: Talk to Me, Goose2025-04-13LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.